HMD Pharma Consultancy
ActiveThe computed 12-month bankruptcy probability of HMD Pharma Consultancy is 2.6% (moderate). The 2025 annual accounts show equity of €75k and a net result of €73k. Its solvency ranks better than 87% of 11297 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
82
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
2.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days only on tighter terms
Liquidity ample (current ratio 5.46; short-term debt: 12.5% and cash: 56.4% of total assets), and 12.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
87.5%
Return on assets
85.1%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-09-2026, 32 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filingDeviation from the deadline
2025
32 d late
← before the deadline
after the deadline →
Financials · fiscal year 2025, micro schema
Equity
€75k
Total assets
€86k
Net result
€73k
Working capital
€48k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Assets €86k
Fixed assets
€27k
Current assets
€59k
Equity and liabilities €86k
Equity
€75k
Debt
€11k
Debt finances 12.5% of the balance-sheet total.
Key figures and ratios
EBITDA
€73k
Cash flow
€73k
Solvency
87.5%
Current ratio
5.46
Quick ratio
5.46
Debt / equity
0.14
ROE
97.3%
ROA
85.1%
Interest coverage
9790.62
Debt
€11k
Debt ≤ 1 year
€11k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Assets
Total assets20/58€86k
Fixed assets21/28€27k
Tangible fixed assets22/27€27k
Plant, machinery and equipment23€1k
Furniture and vehicles24€26k
Current assets29/58€59k
Amounts receivable within one year40/41€10k
Trade receivables40€9k
Other amounts receivable41€2k
Cash at bank and in hand54/58€48k
Equity and liabilities
Total equity and liabilities10/49€86k
Equity10/15€75k
Contributions10/11€2k
Profit (loss) carried forward14€73k
Amounts payable17/49€11k
Amounts payable within one year42/48€11k
Trade debts44€425
Suppliers440/4€425
Other amounts payable47/48€10k
Income statement
Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€416
Other operating charges640/8€735
Gross operating margin9900€74k
Operating profit (loss)9901€73k
Financial charges65/66B€8
Recurring financial charges65€8
Profit (loss) for the period before taxes9903€73k
Profit (loss) for the period9904€73k
Profit (loss) for the period to be appropriated9905€73k
Appropriation of the result
Profit (loss) to be appropriated9906€73k
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
01-09
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 32 days late
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Jans-Molenbeek · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Piersstraat 271080 Sint-Jans-MolenbeekGround area
82 m²
Building footprint
60 m²
Volume, LiDAR
728 m³
Parcel 21522B0017/00D004, Brussels · tallest building 16.0 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
HMD Pharma Consultancy
since 20242.366.574.524
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21522B0017/00D004 | Brussels | 82 m² | 1 · 60 m² | 16.0 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
EUROPE SALES CONSULTING
BE 0887.079.549
Frasnes-lez-Anvaing · Eq €75k
BULTIM
BE 0792.691.225
Waterloo · Eq €75k
CROSSROADS J.S.
BE 0756.768.660
Geel · Eq €75k
P.L. SALES
BE 0445.775.475
Tremelo · Eq €75k
B SMART-TRADE
BE 0823.986.393
Bilzen-Hoeselt · Eq €75k
Of 6,155 companies in sector 46190 we hold annual accounts for 2,570. 1,962 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded16-09-2024
Fiscal year end31-12
Activities, NACEBEL
46190Agents in non-specialised wholesale trade
47750Retail sale of cosmetics and toilet articles
70200Business and other management consultancy
70220Business consulting
82990Other business support services
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:fatima-zohra.hamdaoui@outlook.com